SPONSOR
Inhatarget Therapeutics
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Inhatarget Therapeutics is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including NSCLC (advanced Non-small Cell Lung Cancer), Stage IV Lung Cancer.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Inhatarget Therapeutics
How many clinical trials has Inhatarget Therapeutics sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Inhatarget Therapeutics, of which 1 are actively recruiting participants. These trials cover conditions including NSCLC (advanced Non-small Cell Lung Cancer), Stage IV Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Inhatarget Therapeutics research focus on?
Inhatarget Therapeutics clinical trials span NSCLC (advanced Non-small Cell Lung Cancer), Stage IV Lung Cancer. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Inhatarget Therapeutics clinical trial?
To participate in a Inhatarget Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Inhatarget Therapeutics trials with current recruitment status updated daily.
Clinical Trials by Inhatarget Therapeutics
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology